Incidence of malignancies
| Years on etanercept | ||||
|---|---|---|---|---|
| Parameter | 0–1 (n = 549) | 1–2 (n = 479) | 2–>3 (n = 430) | Total (n = 549) |
| *Includes double-blind and open-label exposure data for those patients who entered the extension trial. | ||||
| Expected cases: 13 based on the National Cancer Institute Surveillance, Epidemiology, and End Results database. | ||||
| Patient-years* | 516 | 455 | 527 | 1498 |
| No of events | 3 | 5 | 3 | 11 |
| Malignancies per 100 patient-years | 0.6 | 1.1 | 0.6 | 0.7 |